These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 2953807)

  • 1. Regulation of Ia+ reticulum cell sarcoma (RCS) growth in syngeneic SJL/J mice. I. Inhibition of tumor growth by passive administration of L3T4 monoclonal antibody before or after tumor inoculation.
    Ohnishi K; Bonavida B
    J Immunol; 1987 Jun; 138(12):4524-9. PubMed ID: 2953807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The in vivo depletion of V beta 17a+ T cells results in the inhibition of reticulum cell sarcoma growth in SJL/J mice. Evidence for the use of anticlonotypic antibody therapy in the control of malignancy.
    Katz JD; Lebow LT; Bonavida B
    J Immunol; 1989 Aug; 143(4):1387-95. PubMed ID: 2663994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of IA positive reticulum cell sarcoma tumor cell growth in syngeneic SJL/J mice by passive administration of monoclonal anti-IA antibody.
    Sakano T; Bonavida B
    Cancer Res; 1986 Jul; 46(7):3245-8. PubMed ID: 3518916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific lymphocyte-target cell conjugate formation between tumor-specific helper T-cell hybridomas and IA-bearing RCS tumors and IE-bearing allogeneic cells. I. Role of Ia and both L3T4 and LFA-1 antigens in recognition/binding.
    Ohnishi K; Bonavida B
    J Immunol; 1986 Dec; 137(11):3681-8. PubMed ID: 2946766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping of SJL/J reticulum cell sarcoma tumor-associated Ia antigens by T cell hybridomas: characterization of tumor-specific and shared epitopes detected on IE+ allogeneic cells.
    Ohnishi K; Bonavida B
    J Immunol; 1986 Jul; 137(2):733-40. PubMed ID: 2424977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular basis of immunologic interactions in adoptive T cell therapy of established metastases from a syngeneic murine sarcoma.
    Ward BA; Shu S; Chou T; Perry-Lalley D; Chang AE
    J Immunol; 1988 Aug; 141(3):1047-53. PubMed ID: 3260908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of B-cell lymphoma growth in syngeneic SJL/J mice. establishment of tumor dormancy following administration of anti-CD4 monoclonal antibody into tumor-bearing mice.
    Ohnishi K; Bonavida B
    Leukemia; 1993 Nov; 7(11):1801-6. PubMed ID: 8231249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular interactions and the role of interleukin 2 in the expression and induction of immunity against a syngeneic murine sarcoma.
    Chou T; Shu S
    J Immunol; 1987 Sep; 139(6):2103-9. PubMed ID: 2957448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serological demonstration of an allogeneic Ia.7 antigen on the cell surface of SJL/J-derived reticulum cell sarcomas.
    Wilbur SM; Marelli O; Bonavida B
    Cancer Res; 1983 Sep; 43(9):4266-70. PubMed ID: 6347368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotype analyses and cellular mechanisms of the pre-effector T-lymphocyte response to a progressive syngeneic murine sarcoma.
    Sakai K; Chang AE; Shu SY
    Cancer Res; 1990 Jul; 50(14):4371-6. PubMed ID: 2114215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RCS tumor-host interactions: tumor growth dependence on L3T4+ T cells and its regulation by suppressor cells.
    Ohnishi K; Bonavida B
    Prog Clin Biol Res; 1987; 244():359-68. PubMed ID: 2958874
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of helper function with anti-Lyt-2 or anti-L3T4 monoclonal antibodies depending on stimulating antigens.
    Guimezanes A; Schmitt-Verhulst AM
    Eur J Immunol; 1985 Dec; 15(12):1187-91. PubMed ID: 2935405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Essential requirement of I-A region-identical host bone marrow or bone marrow-derived cells for tumor neutralization by primed L3T4+ T cells.
    Ozawa H; Iwaguchi T; Kataoka T
    J Immunol; 1987 Dec; 139(11):3896-901. PubMed ID: 2960743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro differentiation of T-cells capable of mediating the regression of established syngeneic tumors in mice.
    Shu S; Chou T; Rosenberg SA
    Cancer Res; 1987 Mar; 47(5):1354-60. PubMed ID: 3102046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of L3T4+ and Lyt-2+ T cells in the IgE response and immunity to Nippostrongylus brasiliensis.
    Katona IM; Urban JF; Finkelman FD
    J Immunol; 1988 May; 140(9):3206-11. PubMed ID: 2966208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ia-restricted interaction of normal lymphoid cells and SJL lymphoma (reticulum cell sarcoma) leading to lymphokine production. III. Relative roles of reticulum cell sarcoma and normal lymphoid cells in lymphokine production.
    Hayama T; Ponzio NM; Nagler C; Vilcek J; Coico RF; Thorbecke GJ
    J Natl Cancer Inst; 1984 Feb; 72(2):321-31. PubMed ID: 6420600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ia-restricted interaction of normal lymphoid cells and SJL lymphoma (reticulum cell sarcoma) leading to lymphokine production. II. Rapid production of antibody-enhancing factor, interleukin 2, and immune interferon.
    Ponzio NM; Hayama T; Nagler C; Katz IR; Hoffmann MK; Gilbert K; Vilcek J; Thorbecke GJ
    J Natl Cancer Inst; 1984 Feb; 72(2):311-20. PubMed ID: 6420599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Requirements for the generation of a Lyt-2+ T-cell proliferative response to a syngeneic tumor in the absence of L3T4+ T-cells.
    Kern DE; Klarnet JP; Cheever MA; Greenberg PD
    Cancer Res; 1990 Oct; 50(19):6256-63. PubMed ID: 2144789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to the L3T4 and Lyt-2 molecules interfere with antigen receptor-driven activation of cloned murine T cells.
    Moldwin RL; Havran WL; Nau GJ; Lancki DW; Kim DK; Fitch FW
    J Immunol; 1987 Aug; 139(3):657-64. PubMed ID: 2955046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of humoral immunity in vivo by monoclonal antibody to L3T4: studies with soluble antigens in intact mice.
    Wofsy D; Mayes DC; Woodcock J; Seaman WE
    J Immunol; 1985 Sep; 135(3):1698-701. PubMed ID: 3160776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.